• ZEBAPROL-AM5 Quick View
    • ZEBAPROL-AM5 Quick View
    • ZEBAPROL-AM5

    • PERFECT WAY TO MANAGE ELEVATED BLOOD PRESSURE COMPOSITION Bisoprolol Fumarate USP 5mg-Amlodipine 5mg INDICATION Hypertension CAD ZEBAPROL-AM5 Highest B, to B, selectively ratio > 80% Controls exercise-induced BP peaks over 24 hours Improves prognosis of HD Increases survival rate in CHF Increases blood flow to the heart muscles to relieve pain due to angina  
    • Read more
  • STAGREL-A 75 Tablets Quick View
    • STAGREL-A 75 Tablets Quick View
    • STAGREL-A 75 Tablets

    • Diminishes the risk of cardiac insufficiency COMPOSITION Clopidogrel Beulfate 75 mg Aspirin 75 mg (Belayered Tabs INDICATION Acute & chronic coronary syndrome Thromboembolic stroke Recurrent ischemic stroke Myocardial infarction Angina Atherosclerosis STAGREL-A 75 Tablets ASPIRIN  An effective antiplatelet drug, lowers the risk of occlusive vascular events by inhibiting platelet aggregation.  Improves inflammatory responses, accelerates platelet function, vascular endothelial cell function and blood coagulation system in patients undergoing Coronary artery  bypass grafting. Clopidogrel A safe and efficacious antiplatelet drug which minimizes ADP-induced platelet aggregation and prolongs bleeding time. Binds selectively and irreversibly to the platelet purinergic P2Y12 receptor, thereby inhibits adenosine diphosphate (ADP)-induced platelet aggregation.  Decreases the incidence of coronary artery stent thrombosis, myocardial infarction and atherosclerotic cerebral infarction
    • Read more
  • SCUBATRIL-50 Quick View
    • SCUBATRIL-50 Quick View
    • SCUBATRIL-50

    • Extend the Life Line...   COMPOSITION Sacubitril 24mg + Valsartan 26mg TABLETS INDICATION Chronic Heart Failure SCUBATRIL-50 The first agent approved in a new class of drugs called angiotensin receptor neprilysin inhibitor FDA approved to treat patients with chronic heart failure with reduced ejection fraction Combination performs better than Enalapril across various heart failure patients and shows substantial benefits in patients with other common comorbidities The PARADIGM-HF trial showed that treatment of heart failure with Valsartan/Sacubitril reduced the risk of the first occurrence of either cardiovascular death or HF-related hospitalization by 20% compared with Enalapril More effective for the management of hypertension patients as compared to ARB  
    • Read more
  • Revosart-AH Quick View
    • Revosart-AH Quick View
    • Revosart-AH

    • Art of Tight Control in Hypertension   COMPOSITION Telmisartan 40mg + Amlodipine 5mg + Hydrochlorothiazide 125 mg. INDICATION Hypertension Myocardial infarction Stroke Angina Oedema Congestive heart failure Revosart-AH: Manages severe and uncontrolled hypertension and significantly reduces mean diastolic blood pressure during nighttime. Improves glucose metabolism in hypertensive patients with metabolic syndrome in addition to antihypertensive effects. This triple combination is effective & well tolerated and improves patient adherence resulting in long-time BP control. Prevents fluid retention in patients with congestive heart failure and treats chronic stable angina and vasospastic angina. It reduces cardiovascular-related mortality in older patients, prevents serious cardiovascular events and helps in stroke and myocardial infarction prophylaxis. Phase III clinical study indicates that the combination of telmisartan, amlodipine and hydrochlorothiazide is more effective than that of only telmisartan and amlodipine at reducing blood pressure in hypertensive patients. (fig 1) (Clinical Therapeutics/Volume 40, Number 1, 2018)  The addition of hydrochlorothiazide provides a suitable treatment option for unresponsive patients.
    • Read more
  • REVOSART-H Tablets Quick View
    • REVOSART-H Tablets Quick View
    • REVOSART-H Tablets

    • When relief from Cardiac Complications becomes a prime concern COMPOSITION Telmisartan I.P. 40 mg + Hydrochlorothiazide I.P. 12.5 mg INDICATION Hypertension Edema Heart Stroke REVOSART-H Tablets Telmisartan • Efficient angiotensin II receptor blocker (ARB) that reduces left ventricular hypertrophy and arterial stiffness and blood pressure! • Shows 67% efficacy as compared to lisinopril in treating hypertension? HCTZ • Reduces risk of myocardial infarction, stroke, or death Shows 63% effiacy in reducing diastolic blood pressure as compared to nicardipine Combination • More tolerant and efficient in reducing the blood pressure than the monotherapies or HCTZ/ atenolol combination  
    • Read more
  • REVOSART-A Tablets Quick View
    • REVOSART-A Tablets Quick View
    • REVOSART-A Tablets

    • An ANTI-HYPERTENSIVE COMBINATION that keeps its promise   COMPOSITION Telmisartan IP 40mg+ Amlodipine Besilate IP 5mg INDICATION Hypertension Heart Stroke Kidney Problems Heart Failure REVOSART-A Tablets This combination works by direct AT-1 receptor blockade and calcium ions inhibition across cell membranes Enlisted as one of the effective choices for the first-line treatment in hypertension.        
    • Read more
  • REVOSART-40 Tablets Quick View
  • LIPOBREC-180 Tablets Quick View
    • LIPOBREC-180 Tablets Quick View
    • LIPOBREC-180 Tablets

    • A Novel Nonstatin Lipid Breaker   COMPOSITION:  Bempedoic Acid 180mg   INDICATIONS:  Hypercholesterolemia Unstable angina Coronary revascularization Diagnosed coronary heart disease Peripheral arterial disease      
    • Read more
  • STAGREL-GOLD Capsules Quick View
    • STAGREL-GOLD Capsules Quick View
    • STAGREL-GOLD Capsules

    • Diminishes the risk of cardiac insufficiency     COMPOSITION: Atorvastatin Calcium IP 20 mg + Clopidogrel (as Bisulphate) IP 75 mg + Aspirin IP 75 mg Improves inflammatory responses, accelerates platelet function & blood coagulation system after coronary artery bypass grafting. Addition of clopidogrel decreases mortality rates by reducing the incidence of thrombotic vascular events in patients with congestive heart failure. Reduces the risk of stroke and also does not increase the risk of hemorrhage in patients with transient ischemic attack. Markedly inhibits (ADP)-mediated platelet aggregation and collagen-induced aggregation in patients with myocardial infarction. INDICATIONS: Acute & chronic coronary syndrome Thromboembolic Stroke Recurrent Ischemic Stroke Myocardial Infarction Angina Atherosclerosis  
    • Read more
  • STAGREL-A & A75 TabletsSTAGREL-A & A75 Tablets Quick View
    • STAGREL-A & A75 TabletsSTAGREL-A & A75 Tablets Quick View
    • STAGREL-A & A75 Tablets

    •  Diminishes the risk of cardiac insuffuciency   COMPOSITION: Stagrel-A: Clopidogrel 75 mg + Aspirin IP 150 mg Starel-A75: Clopidogrel 75 mg + Aspirin IP 75 mg Improves inflammatory responses, accelerates platelet function & blood coagulation system after coronary artery bypass grafting. Addition of clopidogrel decreases mortality rates by reducing the incidence of thrombotic vascular events in patients with congestive heart failure. Reduces the risk of stroke and also does not increase the risk of hemorrhage in patients with transient ischemic attack. Markedly inhibits (ADP)-mediated platelet aggregation and collagen-induced aggregation in patients with myocardial infarction. INDICATIONS: Acute & chronic coronary syndrome Thromboembolic Stroke Recurrent Ischemic Stroke Myocardial Infarction Angina Atherosclerosis
    • Read more
  • ROSACT-A GOLD Capsules Quick View
  • ROSACT-CD Tablets Quick View
    • ROSACT-CD Tablets Quick View
    • ROSACT-CD Tablets

    • An effective way to control cardiovascular disease in hypercholesterolemia   COMPOSITION - Rosuvastatin Calcium 10 mg+ Clopidogrel Bisulphate 75 mg   Treats hypercholesterolemia in patients with cardiovascular disease. Reduces the atherosclerotic events in patients with history of peripheral arterial disease. Effective for hyperlipidemic patients having high risk of the atherosclerosis. Shows synergistic action in the prevention of atherothrombosis. Prevents dyslipidemia associated with risk of myocardial infraction or peripheral vascular disease. Reduces the risk of heart attack in patients with coronary artery disease having high cholesterol levels. Exhibits stronger antithrombotic protection in coronary, cerebral or peripheral arterial diseases. Combination of Rosuvastatin and Clopidogrel is more effective to control heart disease as compare to Rosuvastatin alone.  
    • Read more
  • RESERVE Capsules Quick View
    • RESERVE Capsules Quick View
    • RESERVE Capsules

    • FILLS BODY WITH HEALTH & WELL BEING   COMPOSITION: Resveratrol 50% 50 mg + Grape Seed Ext. 100 mg INDICATIONS: General well being Cardio-vascular health support Maintaining healthy eye & visual function Healthy aging support
    • Read more
  • REPABAY-2 Tablets Quick View
  • RECICARD-TRIO Tablets Quick View
    • RECICARD-TRIO Tablets Quick View
    • RECICARD-TRIO Tablets

    • The Three Pronged Action to Control Hypertension   COMPOSITION: Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Chlorthalidone IP 12.5 mg Minimizes vascular damage, angioedema and improves patient adherence leading to long term BP control. Cardioprotective, dual mode of action reduces the risk of cardiovascular diseases. An open-label study done in India proves that a combination of telmisartan and chlorthalidone is more effective than telmisartan and hydrochlorothiazide. Telmisartan owns a greater anti-hypertensive effect than ramipril, enalapril and perindopril along with end-organ protection beyond BP control. Reduces the need for dose escalation, improves arterial stiffness and offers renoprotection. INDICATIONS: Hypertension Cardiovascular Disorders Arterial Stiffness Angioedema
    • Read more
  • RECICARD-T Tablets Quick View
    • RECICARD-T Tablets Quick View
    • RECICARD-T Tablets

    • The Combat Combination   COMPOSITION: Cilnidipine 10 mg + Telmisartan IP 40 mg  Minimizes vascular damage, angioedema and improves patient adherence leading to long term BP control. Cardioprotective, dual mode of action reduces the risk of cardiovascular diseases. An open-label study done in India proves that a combination of telmisartan and chlorthalidone is more effective than telmisartan and hydrochlorothiazide. Telmisartan owns a greater anti-hypertensive effect than ramipril, enalapril and perindopril along with end-organ protection beyond BP control. Reduces the need for dose escalation, improves arterial stiffness and offers renoprotection. INDICATIONS: Hypertension Cardiovascular Disorders Arterial Stiffness Angioedema
    • Read more